Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
TPA INITIAL COST PER TREATMENT IS OVER $ 100 MORE THAN I.V. STREPTOKINASE AND $ 800 MORE THAN CONVENTIONAL TREATMENT, JOHNS HOPKINS STUDY SHOWS
Apr 04 1988
•
By
The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Archive
More from Pink Sheet